imatinib mesylate has been researched along with DiGeorge Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, BM; Leong, KW; Li, Y; Markx, S; Shteyman, DB; Sun, Y; Sun, Z; Xu, B; Zhu, H | 1 |
1 other study(ies) available for imatinib mesylate and DiGeorge Syndrome
| Article | Year |
|---|---|
Inhibition of Abl Kinase by Imatinib Can Rescue the Compromised Barrier Function of 22q11.2DS Patient-iPSC-Derived Blood-Brain Barriers.
Topics: Blood-Brain Barrier; DiGeorge Syndrome; Endothelial Cells; Humans; Imatinib Mesylate; Induced Pluripotent Stem Cells | 2023 |